No CrossRef data available.
Article contents
Patient outcomes following thyroid surgery for thyrotoxicosis
Published online by Cambridge University Press: 14 March 2022
Abstract
Objective
Total thyroidectomy can be used as a definitive treatment modality for thyrotoxicosis. This study assessed the outcomes of patients treated with surgery at a single secondary care site.
Method
A retrospective cohort study was conducted analysing consecutive patients who underwent thyroid surgery for thyrotoxicosis between 24 November 2000 and 26 April 2019 (n = 595).
Results
Total thyroidectomy was performed in 95.4 per cent of patients. Two-thirds of patients had Graves’ disease histology. Of patients, 22.8 per cent became transiently hypothyroid whilst on levothyroxine (thyroid hormone replacement therapy). Transient and persistent hypocalcaemia was present in 23.3 per cent and 2.8 per cent of patients respectively. Recurrent laryngeal nerve palsy was transient and persistent in 3.6 per cent and 0.3 per cent respectively. Of patients, 2.5 per cent developed post-operative haematomas that required surgical evacuation in the operating theatre.
Conclusion
The overall complication rate for thyroid surgery is higher in thyrotoxic than in euthyroid patients. Compared to other treatment modalities, total thyroidectomy appears to be the most effective, definitive means of managing Graves’ disease.
- Type
- Main Article
- Information
- Copyright
- Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED
Footnotes
Mr D Selwyn takes responsibility for the integrity of the content of the paper
References
Sharma, A, Stan, MN. Thyrotoxicosis: diagnosis and management. Mayo Clin Proc 2019;94:1048–64CrossRefGoogle ScholarPubMed
Ross, DS, Burch, HB, Cooper, DS, Greenlee, MC, Laurberg, P, Luiza Maia, A et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016;26:1343–421CrossRefGoogle ScholarPubMed
Pankhania, M, Mowat, A, Snowden, C, England, J. Post-thyroidectomy haemorrhage in a tertiary centre: analysis of 1280 operations and comparison with the BAETS audit 2012. Clin Otolaryngol 2017;42:484–7CrossRefGoogle Scholar
Gilbert, J. Thyrotoxicosis – investigation and management. Clin Med (Lond) 2017;17:274–7CrossRefGoogle ScholarPubMed
Wong, KK, Shulkin, BL, Gross, MD, Avram, AM. Efficacy of radioactive iodine treatment of Graves’ hyperthyroidism using a single calculated 131I dose. Clin Diabetes Endocrinol 2018;4:20CrossRefGoogle Scholar
Von Elm, E, Altman, DG, Egger, M, Pocock, SJ, Gøtzsche, PC, Vandenbroucke, JP;, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–7CrossRefGoogle ScholarPubMed
Mistry, D, Atkin, S, Atkinson, H, Gunasekaran, S, Sylvester, D, Rigby, AS et al. Predicting thyroxine requirements following total thyroidectomy. Clin Endocrinol (Oxf) 2011;74:384–7CrossRefGoogle ScholarPubMed
Wang, TS, Roman, SA, Sosa, JA. Postoperative calcium supplementation in patient undergoing thyroidectomy. Curr Opin Oncol 2012;24:22–8CrossRefGoogle ScholarPubMed
Varadharajan, K, Choudhury, N. A systematic review of the incidence of thyroid carcinoma in patients undergoing thyroidectomy for thyrotoxicosis. Clin Otolaryngol 2020;45:538–44CrossRefGoogle ScholarPubMed
Papanastasiou, A, Sapalidis, K, Goulis, DG, Michalopoulos, N, Mareti, E, Mantalovas, S et al. Thyroid nodules as a risk factor for thyroid cancer in patients with Graves' disease: a systematic review and meta-analysis of observational studies in surgically treated patients. Clin Endocrinol (Oxf) 2019;91:571–7CrossRefGoogle ScholarPubMed
El Malki, HO, Abouqal, R. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg 2014;101:883CrossRefGoogle ScholarPubMed
Fan, C, Zhou, X, Su, G, Zhou, Y, Su, J, Luo, M et al. Risk factors for neck hematoma requiring surgical re-intervention after thyroidectomy: a systematic review and meta-analysis. BMC Surg 2019;19:98CrossRefGoogle ScholarPubMed
Quimby, AE, Wells, ST, Hearn, M, Javidnia, H, Johnson-Obaseki, S. Is there a group of patients at greater risk for hematoma following thyroidectomy? A systematic review and meta-analysis. Laryngoscope 2017;127:1483–90CrossRefGoogle Scholar
Shinall, MC, Broome, JT, Nookala, R, Shinall, JB, Kiernan, C, Parks, L et al. Total thyroidectomy for Graves' disease: compliance with ATA guidelines may not always be necessary. Surgery 2013;154:1009–15CrossRefGoogle Scholar
Ali, A, Debono, M, Balasubramanian, SP. Outcomes after urgent thyroidectomy following rapid control of thyrotoxicosis in Graves' disease are similar to those after elective surgery in well-controlled disease. World J Surg 2019;43:3051–8CrossRefGoogle ScholarPubMed
Genovese, BM, Noureldine, SI, Gleeson, EM, Tufano, RP, Kandil, E. What is the best definitive treatment for Graves' disease? A systematic review of the existing literature. Ann Surg Oncol 2013;20:660–7CrossRefGoogle ScholarPubMed
Sundaresh, V, Brito, JP, Wang, Z, Prokop, LJ, Stan, MN, Murad, MH et al. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab 2013;98:3671–7CrossRefGoogle ScholarPubMed